MAPT and Alzheimer disease: Moreover, glycogen synthase kinase-3 beta (GSK-3β) has been considered to play an important role in the pathogenesis of type 2 Diabetes Mellitus and AD, where it acts as “tau-kinase I” that contribute to the phosphorylation of tau protein in AD (Hoppe et al. 2010).